A previous study reported that miR-136 suppressed the epithelial-to-mesenchymal transition of cancer cells by regulating the RAS protein activator like 2 (RASAL2) gene in triple-negative breast cancer [36]. Here, RASAL2 is linked to triple-negative breast carcinoma.